Major circadian variations of glucose homeostasis in a patient with Rabson-Mendenhall syndrome and primary insulin resistance due to a mutation (Cys284 → Tyr) in the insulin receptor α-subunit

Pediatric Research

Volumn 42, Issue 1, 1997, Pages 72-77

  Desbois Mouthon, Christèle ^g   Magré, Jocelyne ^g   Duprey, Jacques ^a   Caron, Martine ^g   Blivet Van Eggelpoel, Marie José ^g   Daubas, Claudine ^b   Gourmelen, Micheline ^c   Chevallier, Bertrand ^a   Rizkalla, Salwa ^d   Robert, Jean Jacques ^e   Capeau, Jacqueline ^f  

^a HÔPITAL AMBROISE PARÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d HÔTEL DIEU   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f INSERM   (France)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR; IODINE 125; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; CASE REPORT; CIRCADIAN RHYTHM; GENE MUTATION; GENETIC DISORDER; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; INSULIN BINDING; INSULIN RESISTANCE; MALE; POINT MUTATION; PRIORITY JOURNAL; RABSON MENDENHALL SYNDROME; SYNDROME DELINEATION;

EID: 0030953725     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199707000-00012     Document Type: Article

References (32)

1. Moller DE, O'Rahilly S 1988 Syndromes of severe insulin resistance: clinical and pathophysiological features. In: Moller DE (ed) Insulin Resistance. Wiley. New York, pp 49-81
2. Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, Ou JH, Masiarz F, Kan YW, Goldfine ID, Roth RA, Rutter WJ 1985 The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40:747-758
3. Yang-Feng TL, Francke U, Ullrich A 1985 Gene for human insulin receptor: localization to site on chromosome 19 involved in pre-B-cell leukemia. Science 228:728-731
4. Seino S, Seino M, Bell GI 1990 Human insulin-receptor gene: partial sequence and amplification ofexons by polymerase chain reaction. Diabetes 39:123-128
5. Cheatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142
6. Krook A, Kumar S, Laing I, Boulton AJM, Wass JAH, O'Rahilly S 1994 Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 43:357-368
7. Carrera P, Cordera R, Ferrari M, Cremonesi L, Taramelli R, Andraghetti G, Carducci C, Dozio N, Pozza G, Taylor SI, Micossi P, Barbetti F 1993 Substitution of Leu for Pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance. Hum Mol Genet 2:1437-1441
8. Kadowaki T, Kadowaki H, Rechler MM, Serrano-Rios M, Roth J, Gorden P, Taylor SI 1990 Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. J Clin Invest 86:254-264
9. Müller-Wieland D, van der Vorm ER, Streicher R, Krone W, Seemanova E, Dreyer M, Rüdiger HW, Rosipal SR, Maassen JA 1993 An in-frame insertion in exon 3 and a nonsense mutation in exon 2 of the insulin receptor gene associated with severe insulin resistance in a patient with Rabson-Mendenhall syndrome, Diabetologia 36:1168-1174
10. Roach P, Zick Y, Formisano P, Accili D, Taylor SI, Gorden P 1994 A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing. Diabetes 43:1096-1102
11. Makino H, Taira M, Shimada F, Hashimoto N, Suzuki Y, Nozaki O, Hatanaka Y, Yoshida S 1992 Insulin receptor gene mutation: A molecular genetical and functional analysis. Cell Signal 4:351-363
12. Longo N, Singh R, Griffin LD, Langley SD, Parks JS, Elsas LJ 1994 Impaired growth in Rabson-Mendenhall syndrome: Lack of effect of growth hormone and insulin-like growth factor-I. J Clin Endocrinol Metab 79:799-805
13. Taylor SI 1992 Lilly Lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41:1473-1490
14. Roben JJ, Rakotoambinina B, Cochet I, Foussier V, Magré J, Darmaun D, Chevenne D, Capeau J 1993 The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes. Diabelologia 36:1288-1292
15. Binoux M, Hossenlopp P 1988 Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67:509-514
16. Hossenlopp P, Binoux M 1994 Use of peptides for the detection of binding proteins by western ligand blotting. In. Protein Blotting, a Practical Approach. Oxford University Press, New York, pp 169-186
17. Lalou C, Binoux M 1993 Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the blood-stream. Regul Pept 48:179-188
18. Magré J, Reynet C, Capeau J, Blivet MJ, Picard J 1988 In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Diabetes 37:421-128
19. Gambhir KK, Archer JA, Bradley CJ 1978 Characteristics of human erythrocyte insulin receptors. Diabetes 27:701-708
20. Desbois C, Magré J, Blanquet V, Capeau J, Goossens M, Besmond C 1993 Detection of sequence variations in the human insulin-receptor gene by parallel denaturing gradient gel electrophoresis. Hum Mutat 2:395-403
21. Takata Y, Imamura T, Haruta T, Egawa K, Takada Y, Sawa T, Yang GH, Kobayashi M 1994 Leu 193 mutation in the cysteine rich region of the insulin receptor inhibits the cleavage of the insulin receptor precursor but not insulin binding. Biochem Biophys Res Commun 203:763-772
22. Kadowaki T, Kadowaki H, Accili D, Yazaki Y, Taylor SI 1991 Substitution of arginine for histidine at position 209 in the α-subunit of the human insulin receptor. J Biol Chem 266:21224-21231
23. Maassen JA, Van der Vorm ER, Van der Zon GCM, Klinkhamer MP, Krans HMJ, Möller W 1991 A leucine to protine mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface. Biochemistry 30:10778-10783
24. 281 in the α-subunit of the human insulin receptor causes constitutive activation of the receptor and insulin desensitization. J Clin Endocrinol Metab 81:719-727
25. Perez Corral F, de la Vina S, Carbo M, Barrio R, Yturriaga R, Perez Maceda B, Alonso M, Serrano Rios M 1980 Rabson syndrome: model of insulin resistance due to decreased number and affinity of insulin receptors in erythrocytes. Diabetologia 19:306(abstr)
26. Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, MacCuish AC 1990 Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome. N Engl J Med 323:1425-1426
27. Dozio N, Seavini M, Beretta A, Sartori S, Meschi F, Sarugeri E, Pozza G 1995 In vivo metabolic effects of insulin-like growth factor-I not mediated through the insulin receptor. J Clin Endocrinol Metab 80:1325-1328
28. Thissen JP, Ketelslegers JM, Underwood LE 1994 Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80-101
29. Lee PDK, Conover CA, Powell DR 1993 Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204:4-29
30. Boulware SD, Tamborlane WV, Sherwin RS 1995 Effects of IGF-I on carbohydrate and lipid metabolism. Diabetes Rev 2:196-205
31. Cruz PD, Hud JA 1992 Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol 98:82S-85S
32. Desbois-Mouthon C, Danan C, Amselem S, Blivet-Van Eggelpoel MJ, Sert-Langeron C, Goossens M, Besmond C, Capeau J, Caron M 1996 Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor. Metabolism 45:1493-1500